Ronald Blue Trust, Inc. Amicus Therapeutics, Inc. Transaction History

Ronald Blue Trust, Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Jan 22, 2025	BUY	$9.36 - $12.01 $7,787 - $9,992	832 Added 27.76%	3,829 $36,000
Q3 2024 Oct 17, 2024	BUY	$9.55 - $12.09 $27,036 - $34,226	2,831 Added 1705.42%	2,997 $32,000
Q2 2024 Jul 18, 2024	BUY	$9.04 - $11.75 $1,500 - $1,950	166 New	166 $1,000
Q4 2023 Jan 18, 2024	BUY	$9.97 - $14.52 $2,392 - $3,484	240 New	240 $3,000

312

311M

467K

515K

Ticker FOLD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 280,497,984
Market Cap $2.58B
Description
Amicus Therapeutics, Inc., a biotechnology company, focuses on discovering, developing, and delivering medicines for rare diseases. Its commercial product and product candidates include Galafold, an oral precision medicine for the treatment of adults with a confirmed diagnosis of Fabry disease and an amenable galactosidase alpha gene variant bas...

Get notified when there are updates to the investment portfolio of Ronald Blue Trust, Inc., based on Form 13F filings with the SEC.

Stay updated on Ronald Blue Trust, Inc. with notifications on news.